MMP3 appears to contribute to the multiple molecular aspects of insulin resistance pathogenesis in obesity through inflammation since treatment with an MMP3 inhibitor abolished MMP3-mediated secretion of TNFα. This evidence concerns the gene TNF and Insulin resistance.